Merging chemistry & biology to benefit the lives of patients

Who We Are

Accelerating Breakthroughs

Adcentrx Therapeutics is a clinical-stage biotechnology company focused on accelerating breakthroughs in developing protein conjugate therapeutics for cancer and other life-threatening diseases. Adcentrx strives to develop next generation targeted therapies for improving patient treatment options by combining the targeting precision of biologics and the disease fighting power of small molecule payloads.

Press Releases

Latest News